«
‹
1
...
1061
1062
1063
1064
1065
1066
1067
1068
1069
...
5099
›
»
Page 1065 of 5099 · 254917 entries
Go to
| PDB ID | Title | official curves | Structure unit | Experimental Method |
|---|---|---|---|---|
| 2vrr | Structure of SUMO modified Ubc9 | 1 | 1 | X-RAY DIFFRACTION |
| 2vrs | Structure of avian reovirus sigmaC117-326, C2 crystal form | 1 | 1 | X-RAY DIFFRACTION |
| 2vrt | Crystal Structure of E. coli RNase E possessing M1 RNA fragments - Catalytic Domain | 4 | 4 | X-RAY DIFFRACTION |
| 2vrw | Critical structural role for the PH and C1 domains of the Vav1 exchange factor | 1 | 1 | X-RAY DIFFRACTION |
| 2vrx | Structure of Aurora B kinase in complex with ZM447439 | 2 | 2 | X-RAY DIFFRACTION |
| 2vry | Mouse Neuroglobin with heme iron in the reduced ferrous state | 2 | 2 | X-RAY DIFFRACTION |
| 2vrz | Structural analysis of homodimeric staphylococcal aureus EsxA | 1 | 1 | X-RAY DIFFRACTION |
| 2vs0 | Structural analysis of homodimeric staphylococcal aureus virulence factor EsxA | 1 | 1 | X-RAY DIFFRACTION |
| 2vs1 | The crystal structure of Pyrococcus abyssi tRNA (uracil-54, C5)- methyltransferase in complex with S-adenosyl-L-homocysteine | 1 | 1 | X-RAY DIFFRACTION |
| 2vs2 | Neutron diffraction structure of endothiapepsin in complex with a gem- diol inhibitor. | 1 | 1 | NEUTRON DIFFRACTION |
| 2vs3 | THE BINDING OF UDP-GALACTOSE BY AN ACTIVE SITE MUTANT OF alpha-1,3 GALACTOSYLTRANSFERASE (alpha3GT) | 1 | 1 | X-RAY DIFFRACTION |
| 2vs4 | THE BINDING OF UDP-GALACTOSE BY AN ACTIVE SITE MUTANT OF alpha-1,3 GALACTOSYLTRANSFERASE (alpha3GT) | 1 | 1 | X-RAY DIFFRACTION |
| 2vs5 | THE BINDING OF UDP-GALACTOSE BY AN ACTIVE SITE MUTANT OF alpha-1,3 GALACTOSYLTRANSFERASE (alpha3GT) | 2 | 2 | X-RAY DIFFRACTION |
| 2vs6 | K173A, R174A, K177A-trichosanthin | 2 | 2 | X-RAY DIFFRACTION |
| 2vs7 | The crystal structure of I-DmoI in complex with DNA and Ca | 3 | 3 | X-RAY DIFFRACTION |
| 2vs8 | The crystal structure of I-DmoI in complex with DNA and Mn | 3 | 3 | X-RAY DIFFRACTION |
| 2vsa | Structure and mode of action of a mosquitocidal holotoxin | 1 | 1 | X-RAY DIFFRACTION |
| 2vsc | Structure of the immunoglobulin-superfamily ectodomain of human CD47 | 2 | 2 | X-RAY DIFFRACTION |
| 2vsd | crystal structure of CHIR-AB1 | 1 | 1 | X-RAY DIFFRACTION |
| 2vse | Structure and mode of action of a mosquitocidal holotoxin | 2 | 2 | X-RAY DIFFRACTION |
| 2vsf | Structure of XPD from Thermoplasma acidophilum | 1 | 1 | X-RAY DIFFRACTION |
| 2vsg | A Structural Motif in the Variant Surface Glycoproteins of Trypanosoma Brucei | 1 | 1 | X-RAY DIFFRACTION |
| 2vsh | Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae | 1 | 1 | X-RAY DIFFRACTION |
| 2vsi | Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcus pneumoniae | 1 | 1 | X-RAY DIFFRACTION |
| 2vsk | Hendra virus attachment glycoprotein in complex with human cell surface receptor ephrinB2 | 2 | 2 | X-RAY DIFFRACTION |
| 2vsl | Crystal Structure of XIAP BIR3 with a Bivalent Smac Mimetic | 1 | 1 | X-RAY DIFFRACTION |
| 2vsm | Nipah virus attachment glycoprotein in complex with human cell surface receptor ephrinB2 | 1 | 1 | X-RAY DIFFRACTION |
| 2vsn | Structure and topological arrangement of an O-GlcNAc transferase homolog: insight into molecular control of intracellular glycosylation | 2 | 2 | X-RAY DIFFRACTION |
| 2vso | Crystal Structure of a Translation Initiation Complex | 2 | 2 | X-RAY DIFFRACTION |
| 2vsp | Crystal structure of the fourth PDZ domain of PDZ domain-containing protein 1 | 4 | 4 | X-RAY DIFFRACTION |
| 2vsq | Structure of surfactin A synthetase C (SrfA-C), a nonribosomal peptide synthetase termination module | 1 | 1 | X-RAY DIFFRACTION |
| 2vsr | hPPARgamma Ligand binding domain in complex with 9-(S)-HODE | 2 | 2 | X-RAY DIFFRACTION |
| 2vss | Wild-type Hydroxycinnamoyl-CoA hydratase lyase in complex with acetyl- CoA and vanillin | 1 | 1 | X-RAY DIFFRACTION |
| 2vst | hPPARgamma Ligand binding domain in complex with 13-(S)-HODE | 2 | 2 | X-RAY DIFFRACTION |
| 2vsu | A ternary complex of Hydroxycinnamoyl-CoA Hydratase-Lyase (HCHL) with acetyl-Coenzyme A and vanillin gives insights into substrate specificity and mechanism. | 1 | 1 | X-RAY DIFFRACTION |
| 2vsv | Crystal structure of the PDZ domain of human rhophilin-2 | 3 | 3 | X-RAY DIFFRACTION |
| 2vsw | The structure of the rhodanese domain of the human dual specificity phosphatase 16 | 3 | 3 | X-RAY DIFFRACTION |
| 2vsx | Crystal Structure of a Translation Initiation Complex | 3 | 3 | X-RAY DIFFRACTION |
| 2vsy | Xanthomonas campestris putative OGT (XCC0866), apostructure | 2 | 2 | X-RAY DIFFRACTION |
| 2vsz | Crystal Structure of the ELMO1 PH domain | 1 | 1 | X-RAY DIFFRACTION |
| 2vt0 | X-ray structure of a conjugate with conduritol-beta-epoxide of acid-beta-glucosidase overexpressed in cultured plant cells | 2 | 2 | X-RAY DIFFRACTION |
| 2vt1 | Crystal structure of the cytoplasmic domain of Spa40, the specificity switch for the Shigella flexneri Type III Secretion System | 1 | 1 | X-RAY DIFFRACTION |
| 2vt2 | Structure and functional properties of the Bacillus subtilis transcriptional repressor Rex | 1 | 1 | X-RAY DIFFRACTION |
| 2vt3 | Structure and functional properties of the Bacillus subtilis transcriptional repressor Rex | 1 | 1 | X-RAY DIFFRACTION |
| 2vt4 | TURKEY BETA1 ADRENERGIC RECEPTOR WITH STABILISING MUTATIONS AND BOUND CYANOPINDOLOL | 6 | 6 | X-RAY DIFFRACTION |
| 2vt5 | FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE -1- PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH A DUAL BINDING AMP SITE INHIBITOR | 2 | 2 | X-RAY DIFFRACTION |
| 2vt6 | Native Torpedo californica acetylcholinesterase collected with a cumulated dose of 9400000 Gy | 1 | 1 | X-RAY DIFFRACTION |
| 2vt7 | Native Torpedo californica acetylcholinesterase collected with a cumulated dose of 800000 Gy | 1 | 1 | X-RAY DIFFRACTION |
| 2vt8 | Structure of a conserved dimerisation domain within Fbox7 and PI31 | 2 | 2 | X-RAY DIFFRACTION |
| 2vta | Identification of N-(4-piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H- pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design. | 1 | 1 | X-RAY DIFFRACTION |